Barriers to the identification of familial hypercholesterolemia among primary care providers

被引:29
作者
Zimmerman, John [1 ]
Duprez, Daniel [2 ]
Veach, Patricia McCarthy [3 ]
Zierhut, Heather A. [3 ]
机构
[1] Univ Texas Southwestern, Canc Genet Program, Dallas, TX USA
[2] Univ Minnesota Twin Cities, Div Cardiol, Minneapolis, MN USA
[3] Univ Minnesota Twin Cities, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA
关键词
Familial hypercholesterolemia; Provider education; Universal screening; Cholesterol screening; Heart disease; Hypercholesterolemia; ELECTRONIC HEALTH RECORDS; DECISION-SUPPORT; HEART-DISEASE; PHARMACOGENOMICS; IMPLEMENTATION; GENETICS; GUIDANCE; GAPS;
D O I
10.1007/s12687-018-0383-3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Familial hypercholesterolemia (FH) is severely underdiagnosed in the USA. Primary care providers are well-positioned to identify FH cases; however, universal FH screening is not routinely implemented in practice. The aim of the present study was to identify perceived barriers to FH screening among primary care physicians in Minnesota. A questionnaire assessed FH screening practices, knowledge, and perceived barriers to FH screening. The questionnaire, sent electronically to internal and family medicine physicians in Minnesota (N=1932) yielded a conservative estimated response rate of 9% (N=173). Although 92% of participants reported themselves responsible for identifying individuals with FH, 30% did not routinely perform screening in practice. Only 50% of participants were able to correctly identify the risk of FH to first-degree relatives of individuals with FH. Challenges incorporating lipid and family history data was the most frequently endorsed barrier to FH screening (34%). A majority of participants endorsed a clinical decision support system that flags individuals at high risk for FH (62%) and an algorithm with cholesterol levels and lipid disorders (56%) as means of facilitating FH screening. Although the generalizability of the findings is unknown, the results underscore the need for increased provider education regarding FH and suggest an FH screening strategy incorporating a clinical decision support system, screening algorithm, and support from other healthcare providers.
引用
收藏
页码:229 / 236
页数:8
相关论文
共 42 条
[1]  
[Anonymous], 2015, CIRCULATION, DOI DOI 10.1161/CIR.0000000000000152
[2]  
[Anonymous], 2014, Tier 1 Genomics Applications and their Importance to Public Health | CDC
[3]  
[Anonymous], MOR DET INF KEY TIER
[4]  
[Anonymous], LIP DIS AD CHOL DYSL
[5]  
[Anonymous], PRIMARY CARE
[6]  
[Anonymous], 1999, Familial hypercholesterolaemia (FH): report of a second WHO consultation, Geneva
[7]   Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: An Australian experience [J].
Bell, Damon A. ;
Pang, Jing ;
Burrows, Sally ;
Bates, Timothy R. ;
van Bockxmeer, Frank M. ;
Hooper, Amanda J. ;
O'Leary, Peter ;
Burnett, John R. ;
Watts, Gerald F. .
ATHEROSCLEROSIS, 2015, 239 (01) :93-100
[8]   Familial Hypercholesterolaemia in Primary Care: Knowledge and Practices among General Practitioners in Western Australia [J].
Bell, Damon A. ;
Garton-Smith, Jacquie ;
Vickery, Alistair ;
Kirke, Andrew B. ;
Pang, Jing ;
Bates, Timothy R. ;
Watts, Gerald F. .
HEART LUNG AND CIRCULATION, 2014, 23 (04) :309-313
[9]  
Blankenship M, 1989, Nurs Manage, V20, P81, DOI 10.1097/00006247-198902000-00022
[10]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47